Skip to content
City AM
Main navigation
Download free app
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Banking
      • Tech
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • Abu Dhabi Finance Week
      • AON
      • Bayes Business School
      • City of London BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Hercules
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      Starmer: UK not involved in Venezuela strikes

      Keir Starmer's business adviser is reportedly being considering to become the UK's ambassador in the US.

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
      • The Punter
    • From our partners
      • The Morning Briefing: SBS x City AM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Three sport law disputes to watch for in 2026

      GettyImages 2250193910 likely depicts a business meeting or conference with diverse professionals discussing strategic plans.

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • New Openings
      • Toast the City Awards
      • The Magazine
      • City Winners
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      The 13 unmissable TV shows to watch in 2026, from Industry to Bridgerton

      Breaking news event on December 22, 2025, featuring a significant crowd gathered at a major city square during sunset.

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Readership Survey 2025
  • City AM Events
  • Newsletters
  • Latest Paper
  • Sign In
  • Sign Out
  • My Account

Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong.

Take 2 mins to learn more at www.coinbase.com/uk-fca-info

UK health

  • ‘Some of the benefits are fairly boring, but they save lives’: AI chief on transforming the NHS

    healthcare

    AI in healthcare might spark visions of robotic doctors and futuristic diagnostics. But Robbie Jerrom, senior principal technologist for AI at Red Hat, insists the real gains lie in the mundane systems that make the NHS run more efficiently. “Prioritising summarising email requests or patient call logs… they’re not very exciting, but they consume a [...]

    Brit are seeking financial support from the ‘Bank of Mum and Dad’ to afford private healthcare.
  • Should the wealthy always go private to save the NHS?

    healthcare

    It’s no secret that the NHS has been under pressure for years and the strain on its resources looks like not letting up any time soon. With staffing shortages, long waiting times, funding issues, an aging population and a rise in demand, the NHS has its back up against the wall. But should those who [...]

    The CEO of Bupa in the UK is the latest guest on City AM's Boardroom Uncovered show. (Photo by John Keeble/Getty Images)
  • Mounjaro and Wegovy demand helps Chemist4U sales double

    healthcare

    Increasing demand for weight-loss jabs such as Mounjaro and Wegovy has helped sales at the firm behind online pharmacy Chemist4U almost double. The Skelmersdale-based business has reported a turnover of £59.5m for the year to 30 September, 2024, according to new accounts filed with Companies House. The latest total comes after the firm behind Chemist4U [...]

    Sales at the company behind Chemist4U have doubled thanks to the demand for weight-loss drugs. (Photo Illustration by Scott Olson/Getty Images)
  • PureGym: Losses near £90m amid huge expansion drive

    May 29, 2025

    Losses at PureGym widened to almost £90m as it created hundreds of jobs and opened new locations in 2024, it has been revealed. The Leeds-headquartered low-cost chain has posted a pre-tax loss of £88.5m for its latest financial year, after having also lost £77.6m in the prior 12 months. In 2024, PureGym increased its headcount [...]

  • Vitality: ‘Why your health and life insurance premium won’t go down’

    February 18, 2025

    In this episode of Boardroom Uncovered, Neville Koopowitz, the chief executive of health and life insurance giant Vitality.

  • Vitality to offer discounted weight loss drugs in UK first

    February 12, 2025

    Customers are to be offered discounted weight loss treatments through insurance giant Vitality in a UK first. The group, which is UK’s third-largest health insurer behind Bupa and Axa, is to offer discounts of up to 20 per cent for medications such as Wegovy and Mounjaro to its 1.9 million members. The offer is to [...]

  • Record profit for Totally Wicked ahead of single-use vapes ban as sales double in two years

    January 2, 2025

    Profit at Totally Wicked has surged to a new record level ahead of the sale of single-use disposable vapes being banned in England and Wales later this year. The Lancashire-headquartered has reported a pre-tax profit of £8.1m for the 12 months to 31 March, 2024, up from the £3.3m it posted for the prior year. [...]

  • Mydentist looks to India for new recruits as loss widens

    November 20, 2024

    Mydentist has sunk further into the red as it looks to recruit more new hires from overseas after the UK Government relaxed the rules. The business, which is one of the largest dental providers in the UK, has said hiring has been constrained by the limited number of dental school places in this country as [...]

  • Astrazeneca boosts cardiovascular pipeline with licensing deal

    October 7, 2024

    Astrazeneca has struck a licensing agreement worth up to $2bn (£1.5bn) with China’s CPSC Pharmaceutical Group to develop a new cardiovascular drug, the company announced on Monday. The Anglo-Swedish pharmaceutical giant will pay $100m (£76.5) upfront, with additional milestone payments of up to $1.9bn (£1.4bn), to licence a preclinical small molecule aimed at treating dyslipidemia. [...]

Trending Articles

  • City AM’s 10 stock picks for 2026

  • UK’s first high-speed railway HS1 faced cancellation months before Channel Tunnel opening

  • FTSE 100 closes whisker away from 10,000 after intraday high

  • Uber prices set to soar as ministers introduce VAT crackdown

  • Our honest review of new Emirates cabins central to airline’s £3.7 billion upgrade

Subscribe

Subscribe to the City AM newsletter to have our top stories delivered directly to your inbox.

Subscribe
  • Got a story?
  • About City AM
  • Careers
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance
  • City AM Events
  • City AM Curated
  • The Punter
  • City Winners
  • Casino

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
  • Newsletters
  • Advertising
  • About
  • Tickets
Copyright 2026 City AM Limited